Detailed Instructions: In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.
See one example below:
Problem: SECTION 1. LIABILITY OF BUSINESS ENTITIES PROVIDING USE OF FACILITIES
TO NONPROFIT ORGANIZATIONS.

(a) Definitions.--In this section:
(1) Business entity.--The term ''business entity'' means a
firm, corporation, association, partnership, consortium, joint
venture, or other form of enterprise.
(2) Facility.--The term ''facility'' means any real
property, including any building, improvement, or appurtenance.
(3) Gross negligence.--The term ''gross negligence'' means
voluntary and conscious conduct by a person with knowledge (at
the time of the conduct) that the conduct is likely to be
harmful to the health or well-being of another person.
(4) Intentional misconduct.--The term ''intentional
misconduct'' means conduct by a person with knowledge (at the
time of the conduct) that the conduct is harmful to the health
or well-being of another person.
(5) Nonprofit organization.--The term ''nonprofit
organization'' means--
(A) any organization described in section 501(c)(3)
of the Internal Revenue Code of 1986 and exempt from
tax under section 501(a) of such Code; or
(B) any not-for-profit organization organized and
conducted for public benefit and operated primarily for
charitable, civic, educational, religious, welfare, or
health purposes.
(6) State.--The term ''State'' means each of the several
States, the District of Columbia, the Commonwealth of Puerto
Rico, the Virgin Islands, Guam, American Samoa, the Northern
Mariana Islands, any other territory or possession of the
United States, or any political subdivision of any such State,
territory, or possession.
(b) Limitation on Liability.--
(1) In general.--Subject to subsection (c), a business
entity shall not be subject to civil liability relating to any
injury or death occurring at a facility of the business entity
in connection with a use of such facility by a nonprofit
organization if--
(A) the use occurs outside of the scope of business
of the business entity;
(B) such injury or death occurs during a period
that such facility is used by the nonprofit
organization; and
(C) the business entity authorized the use of such
facility by the nonprofit organization.
(2) Application.--This subsection shall apply--
(A) with respect to civil liability under Federal
and State law; and
(B) regardless of whether a nonprofit organization
pays for the use of a facility.
(c) Exception for Liability.--Subsection (b) shall not apply to an
injury or death that results from an act or omission of a business
entity that constitutes gross negligence or intentional misconduct,
including any misconduct that--
(1) constitutes a crime of violence (as that term is
defined in section 16 of title 18, United States Code) or act
of international terrorism (as that term is defined in section
2331 of title 18) for which the defendant has been convicted in
any court;
(2) constitutes a hate crime (as that term is used in the
Hate Crime Statistics Act (28 U.S.C. 534 note));
(3) involves a sexual offense, as defined by applicable
State law, for which the defendant has been convicted in any
court; or
(4) involves misconduct for which the defendant has been
found to have violated a Federal or State civil rights law.
(d) Superseding Provision.--
(1) In general.--Subject to paragraph (2) and subsection
(e), this Act preempts the laws of any State to the extent that
such laws are inconsistent with this Act, except that this Act
shall not preempt any State law that provides additional
protection from liability for a business entity for an injury
or death with respect to which conditions under subparagraphs
(A) through (C) of subsection (b)(1) apply.
(2) Limitation.--Nothing in this Act shall be construed to
supersede any Federal or State health or safety law.
(e) Election of State Regarding Nonapplicability.--This Act shall
not apply to any civil action in a State court against a business
entity in which all parties are citizens of the State if such State
enacts a statute--
(1) citing the authority of this subsection;
(2) declaring the election of such State that this Act
shall not apply to such civil action in the State; and
(3) containing no other provision.
Solution: Shields a business entity from civil liability relating to any injury or death occurring at a facility of that entity in connection with a use of such facility by a nonprofit organization if: (1) the use occurs outside the scope of business of the business entity; (2) such injury or death occurs during a period that such facility is used by such organization; and (3) the business entity authorized the use of such facility by the organization.
Makes this Act inapplicable to an injury or death that results from an act or omission of a business entity that constitutes gross negligence or intentional misconduct, including misconduct that: (1) constitutes a hate crime or a crime of violence or act of international terrorism for which the defendant has been convicted in any court; or (2) involves a sexual offense for which the defendant has been convicted in any court or misconduct for which the defendant has been found to have violated a Federal or State civil rights law.
Preempts State laws to the extent that such laws are inconsistent with this Act, except State law that provides additional protection from liability. Specifies that this Act shall not be construed to supersede any Federal or State health or safety law.
Makes this Act inapplicable to any civil action in a State court against a business entity in which all parties are citizens of the State if such State, citing this Act's authority and containing no other provision, enacts a statute declaring the State's election that this Act shall not apply to such action in the State.
Explanation: This Bill focuses on shielding business entities from civil liability relating to an injury or death depending on the conditions of injury, hence the generated summary is correct.

Problem: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Congenital Heart Futures Act''.

SEC. 2. FINDINGS.

Congress finds the following:
(1) Congenital heart defects are the most common and most
deadly group of birth defects and affect nearly 1 percent of
all live births, approximately 36,000 births a year. A child is
born with a congenital heart defect every 15 minutes.
(2) Congenital heart disease is a rapidly growing national
health problem. Childhood survival has risen from below 20
percent in 1950 to more than 90 percent today. Due to the
increase in childhood survival, the congenital heart disease
population increases by an estimated 5 percent every year.
(3) Approximately 800,000 children and 1,000,000 adults in
the United States are now living with congenital heart disease
and require highly specialized life-long cardiac care.
(4) There is no cure for congenital heart disease. Even
survivors of successful childhood treatment can face life-long
risks from congenital heart disease, including heart failure,
rhythmic disorders, stroke, renal dysfunction, and
neurocognitive dysfunction.
(5) Less than 10 percent of adults living with complex
congenital heart disease currently receive recommended cardiac
care. Many individuals with congenital heart disease are
unaware that they require life-long specialized health
surveillance. Delays in care can result in premature death and
disability.
(6) The estimated life expectancy for those with congenital
heart disease is significantly lower than for the general
population. The life expectancy for those born with moderately
complex heart defects is 55, while the estimated life
expectancy for those born with highly complex defects is
between 35 and 40.
(7) Despite the prevalence and seriousness of the disease,
Federal research, data collection, education, and awareness
activities are limited.
(8) The strategic plan of the National Heart, Lung, and
Blood Institute completed in 2007 notes that ''successes over
several decades have enabled people with congenital heart
diseases to live beyond childhood, but too often inadequate
data are available to guide their treatment as adults''.
(9) The strategic plan for the Division of Cardiovascular
Diseases at the National Heart, Lung, and Blood Institute,
completed in 2008, set goals for congenital heart disease
research, including understanding the development and genetic
basis of congenital heart disease, improving evidence-based
care and treatment of children with congenital and acquired
pediatric heart disease, and improving evidence-based care and
treatment of adults with congenital heart disease.

SEC. 3. PUBLIC EDUCATION AND AWARENESS OF CONGENITAL HEART DISEASE.

Title III of the Public Health Service Act (42 U.S.C. 241 et seq.)
is amended by adding at the end the following:

''PART S--PROGRAMS RELATING TO CONGENITAL HEART DISEASE

''SEC. 399HH. PUBLIC EDUCATION AND AWARENESS OF CONGENITAL HEART
DISEASE.

''(a) In General.--The Secretary, acting through the Director of
the Centers for Disease Control and Prevention and in collaboration
with appropriate congenital heart disease patient organizations and
professional organizations, may, directly or through grants,
cooperative agreements, or contracts to eligible entities, conduct,
support, and promote a comprehensive public education and awareness
campaign to increase public and medical community awareness regarding
congenital heart disease, including the need for life-long treatment of
congenital heart disease survivors.
''(b) Eligibility for Grants.--To be eligible to receive a grant,
cooperative agreement, or contract under this section, an entity shall
be a State or private nonprofit entity and shall submit to the
Secretary an application at such time, in such manner, and containing
such information as the Secretary may require.''.

SEC. 4. NATIONAL CONGENITAL HEART DISEASE REGISTRY.

Title III of the Public Health Service Act (42 U.S.C. 241 et seq.),
as amended by section 3, is further amended by adding at the end the
following:

''SEC. 399II. NATIONAL CONGENITAL HEART DISEASE REGISTRY.

''(a) In General.--The Secretary, acting through the Director of
the Centers for Disease Control and Prevention, may--
''(1) enhance and expand infrastructure to track the
epidemiology of congenital heart disease and to organize such
information into a comprehensive, nationwide registry of actual
occurrences of congenital heart disease, to be known as the
'National Congenital Heart Disease Registry'; or
''(2) award a grant to one eligible entity to undertake the
activities described in paragraph (1).
''(b) Purpose.--The purpose of the Congenital Heart Disease
Registry shall be to facilitate further research into the types of
health services patients use and to identify possible areas for
educational outreach and prevention in accordance with standard
practices of the Centers for Disease Control and Prevention.
''(c) Content.--The Congenital Heart Disease Registry--
''(1) may include information concerning the incidence and
prevalence of congenital heart disease in the United States;
''(2) may be used to collect and store data on congenital
heart disease, including data concerning--
''(A) demographic factors associated with
congenital heart disease, such as age, race, ethnicity,
sex, and family history of individuals who are
diagnosed with the disease;
''(B) risk factors associated with the disease;
''(C) causation of the disease;
''(D) treatment approaches; and
''(E) outcome measures, such that analysis of the
outcome measures will allow derivation of evidence-
based best practices and guidelines for congenital
heart disease patients; and
''(3) may ensure the collection and analysis of
longitudinal data related to individuals of all ages with
congenital heart disease, including infants, young children,
adolescents, and adults of all ages, including the elderly.
''(d) Coordination With Federal, State, and Local Registries.--In
establishing the National Congenital Heart Registry, the Secretary may
identify, build upon, expand, and coordinate among existing data and
surveillance systems, surveys, registries, and other Federal public
health infrastructure, including--
''(1) State birth defects surveillance systems;
''(2) the State birth defects tracking systems of the
Centers for Disease Control and Prevention;
''(3) the Metropolitan Atlanta Congenital Defects Program;
and
''(4) the National Birth Defects Prevention Network.
''(e) Public Access.--The Congenital Heart Disease Registry shall
be made available to the public, including congenital heart disease
researchers.
''(f) Patient Privacy.--The Secretary shall ensure that the
Congenital Heart Disease Registry is maintained in a manner that
complies with the regulations promulgated under section 264 of the
Health Insurance Portability and Accountability Act of 1996.
''(g) Eligibility for Grant.--To be eligible to receive a grant
under subsection (a)(2), an entity shall--
''(1) be a public or private nonprofit entity with
specialized experience in congenital heart disease; and
''(2) submit to the Secretary an application at such time,
in such manner, and containing such information as the
Secretary may require.''.

SEC. 5. ADVISORY COMMITTEE ON CONGENITAL HEART DISEASE.

Title III of the Public Health Service Act (42 U.S.C. 241 et seq.),
as amended by section 4, is further amended by adding at the end the
following:

''SEC. 399JJ. ADVISORY COMMITTEE ON CONGENITAL HEART DISEASE.

''(a) Establishment.--The Secretary, acting through the Director of
the Centers for Disease Control and Prevention, may establish an
advisory committee, to be known as the 'Advisory Committee on
Congenital Heart Disease' (referred to in this section as the 'Advisory
Committee').
''(b) Membership.--The members of the Advisory Committee may be
appointed by the Secretary, acting through the Centers for Disease
Control and Prevention, and shall include--
''(1) at least one representative from--
''(A) the National Institutes of Health;
''(B) the Centers for Disease Control and
Prevention; and
''(C) a national patient advocacy organization with
experience advocating on behalf of patients living with
congenital heart disease;
''(2) at least one epidemiologist who has experience
working with data registries;
''(3) clinicians, including--
''(A) at least one with experience diagnosing or
treating congenital heart disease; and
''(B) at least one with experience using medical
data registries; and
''(4) at least one publicly or privately funded researcher
with experience researching congenital heart disease.
''(c) Duties.--The Advisory Committee may review information and
make recommendations to the Secretary concerning--
''(1) the development and maintenance of the National
Congenital Heart Disease Registry established under section
399II;
''(2) the type of data to be collected and stored in the
National Congenital Heart Disease Registry;
''(3) the manner in which such data is to be collected;
''(4) the use and availability of such data, including
guidelines for such use; and
''(5) other matters, as the Secretary determines to be
appropriate.
''(d) Report.--Not later than 180 days after the date on which the
Advisory Committee is established and annually thereafter, the Advisory
Committee shall submit a report to the Secretary concerning the
information described in subsection (c), including recommendations with
respect to the results of the Advisory Committee's review of such
information.''.

SEC. 6. CONGENITAL HEART DISEASE RESEARCH.

Subpart 2 of part C of title IV of the Public Health Service Act
(42 U.S.C. 285b et seq.) is amended by adding at the end the following:

''SEC. 425. CONGENITAL HEART DISEASE.

''(a) In General.--The Director of the Institute may expand,
intensify, and coordinate research and related activities of the
Institute with respect to congenital heart disease, which may include
congenital heart disease research with respect to--
''(1) causation of congenital heart disease, including
genetic causes;
''(2) long-term outcomes in individuals with congenital
heart disease, including infants, children, teenagers, adults,
and elderly individuals;
''(3) diagnosis, treatment, and prevention;
''(4) studies using longitudinal data and retrospective
analysis to identify effective treatments and outcomes for
individuals with congenital heart disease; and
''(5) identifying barriers to life-long care for
individuals with congenital heart disease.
''(b) Coordination of Research Activities.--The Director of the
Institute may coordinate research efforts related to congenital heart
disease among multiple research institutions and may develop research
networks.
''(c) Minority and Medically Underserved Communities.--In carrying
out the activities described in this section, the Director of the
Institute shall consider the application of such research and other
activities to minority and medically underserved communities.''.

SEC. 7. AUTHORIZATION OF APPROPRIATIONS.

There are authorized to be appropriated to carry out the amendments
made by this Act such sums as may be necessary for each of fiscal years
2010 through 2014.
Solution:
Congenital Heart Futures Act - Amends the Public Health Service Act to authorize the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC) in collaboration with appropriate congenital heart disease patient organizations and professional organizations, to conduct, support, and promote a comprehensive public education campaign to increase awareness regarding congenital heart disease, including the need for lifelong treatment.

Authorizes the Secretary to: (1) award a grant to one entity to enhance and expand infrastructure to track the epidemiology of congenital heart disease and to organize such information into a comprehensive National Congenital Heart Disease Registry with the purpose of facilitating research into the types of health services patients use and identifying possible areas for educational outreach and prevention; and (2) establish an Advisory Committee on Congenital Heart Disease.

Authorizes the Director of the National Heart, Lung, and Blood Institute to expand, intensify, and coordinate research and related activities of the Institute regarding congenital heart disease.